menu search

Candel therapeutics presents preclinical data from its enlighten™ discovery platform at sitc

The first experimental agent from the enLIGHTEN™ Discovery Platform is Alpha-201-macro1, an investigational viral immunotherapy designed to activate...

November 4, 2023, 12:00 pm

Coherus presents data from next-generation immuno-oncology programs at 38th annual meeting of society for immunotherapy of cancer (sitc)

– Data demonstrate distinct IL-27-mediated expression of genes associated with immune suppression in ...

November 3, 2023, 12:30 pm

Apple is not really immune to consumer softness, says bofa's wamsi mohan

Wamsi Mohan, Bank of America Securities senior analyst, joins 'Squawk Box' to break down Apple's quarterly earnings results, which beat on top and bot...

November 3, 2023, 8:31 am

Gracell biotechnologies to participate in four upcoming investor conferences

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDA...

November 1, 2023, 4:00 pm

Uk regulator approves pfizer's hair loss drug

Britain's medicines regulator on Wednesday approved Pfizer Inc's drug to treat hair loss caused by an autoimmu...

November 1, 2023, 7:39 am

Argenx to present at upcoming investor conferences

November 1, 2023 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of peop...

November 1, 2023, 2:00 am

Omega therapeutics presents new preclinical data demonstrating pre-transcriptional modulation of multiple cxcl genes by a single epigenomic controller

Coordinated modulation of epigenetic profile of CXCL1-8 genes with corresponding downregulation of gene expression and protein levels, and inhibition ...

October 31, 2023, 11:00 am

Adaptimmune therapeutics plc (adap) suffers a larger drop than the general market: key insights

The latest trading day saw Adaptimmune Therapeutics PLC (ADAP) settling at $0.55, representing a -1.79%...

October 27, 2023, 7:33 pm

Are medical stocks lagging alcon (alc) this year?

Here is how Alcon (ALC) and Alpine immune Sciences, Inc. (ALPN) have performed compared to their sector...

October 27, 2023, 11:18 am

Abbvie results beat expectations despite low-cost competition to blockbuster humira

AbbVie Inc. ABBV, -0.04% on Friday reported third-quarter sales and profit that topped analyst expectations and raised its full-year earnings outlook,...

October 27, 2023, 7:42 am

Pfizer's combination flu and covid vaccine candidates effective, trial data shows

Shares of Pfizer Inc (NYSE:PFE) and its German partner BioNTech rose after the two companies announced positive results from a Phase 1/2 study evalua...

October 26, 2023, 2:45 pm

Pfizer, biontech say flu-covid shot generates immune response

Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a strong ...

October 26, 2023, 6:53 am

Sensei biotherapeutics to present initial clinical data from dose escalation trial of sns-101 at 2023 sitc annual meeting

BOSTON, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discove...

October 25, 2023, 9:05 am

Adaptimmune to report q3 2023 financial and business updates on wednesday, november 8, 2023

Philadelphia, Pennsylvania and Oxfordshire, United Kingdom--(Newsfile Corp. - October 25, 2023) - Adaptimmune<...

October 25, 2023, 8:06 am

Fate therapeutics to webcast conference call reporting third quarter 2023 financial results

SAN DIEGO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage ...

October 25, 2023, 8:00 am

Altimmune to present new data on the anti-inflammatory and anti-fibrotic properties of pemvidutide in a late-breaking presentation at the liver meeting® 2023

GAITHERSBURG, Md., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage bi...

October 25, 2023, 7:30 am

Biostax announces finra approval for name and ticker symbol change, signals entry into global substance abuse commercial markets and pioneering hiv treatment

ORLANDO, Fla., Oct. 24, 2023 (GLOBE NEWSWIRE) — Biostax Corp (OTC Pink: BTAX), a leading public company specializing in healthcare solutions, today ...

October 24, 2023, 1:15 pm

Is ac immune (aciu) stock outpacing its medical peers this year?

Here is how AC immune (ACIU) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their s...

October 24, 2023, 11:18 am

Argenx to report third quarter 2023 financial results and business update on october 31, 2023

October 24, 2023 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of peop...

October 24, 2023, 1:00 am


Search within

Pages Search Results: